Company Data
Autolus Therapeutics plc
Ticker
AUTL
Current Price
$1.65 -5.71%
Market Cap
$439.2M
Price Target
Refer to Report
Volume
729.1K
52wk Range
$1.175 - $2.7
Overview
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company’s clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.